Showing results (2801-2810 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|May 26, 2022
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance studyPascale Palassin, Alexandre T J Maria, Chayma Ladhari, et al.Cancer Immunology, Immunotherapy : CII|July 17, 2021
Transcriptomic signatures of tumors undergoing T cell attackAishwarya Gokuldass, Aimilia Schina, Martin Lauss, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2021
Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinomaMasahiro Ohira, Ryuichi Hotta, Yuka Tanaka, et al.Cancer Immunology, Immunotherapy : CII|July 20, 2021
Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21Jaya Lakshmi Thangaraj, Minh-Trang Thi Phan, SoonHo Kweon, et al.Cancer Immunology, Immunotherapy : CII|May 13, 2022
In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapyXu-Dong Tang, Kui-Lin Lü, Jin Yu, et al.Cancer Immunology, Immunotherapy : CII|May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studiesV Moreno, E Calvo, M R Middleton, et al.Cancer Immunology, Immunotherapy : CII|July 1, 2022
Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor modelMichelle A Hsu, Stephanie M Okamura, C Daniel De Magalhaes Filho, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor stateS Sone, T Utsugi, P Tandon, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixturesY Suzuki, K Suzuki, M Hosokawa, et al.Cancer Immunology, Immunotherapy : CII|April 29, 2008
Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunityShinjiro Yamaguchi, Tomohide Tatsumi, Tetsuo Takehara, et al.Pageof 652